H&F Corporate Investors X, Ltd.
CIK
1901930
Location
San Francisco, CA
Portfolio Value
Mid
$2,795,283,417
Diversification
Highly concentrated
Reports for
Hellman & Friedman Investors X, L.P.
Filing Date
Global Rank
#1,311
/ 8,798
▼ 414
· as of Jun 2026
Top Industry
Medical Instruments & Supplies
100.0%
3Y Alpha vs SPY
-29.2%
Period ended 3 months ago
Filed Aug 12, 2026 · 2mo
11 quarters · since Mar 2022
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
1 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
100.0%
0.0 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
10,000
Highly concentrated0
Portfolio Trend
11 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $2,795,283,417 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MDLN | Medline Inc. | −15,599,171 | 70,874,326 | $2,795,283,417 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
1 tracked positions ·
$2,795,283,417 total
· filing declares
1 positions · $2,795,283,417
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| MDLN |
Medline Inc.
Healthcare
|
Reduced | 70,874,326 | $2,795,283,417 | 100.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.